📰 Genmark Diagnostic News
Genmark Diagnostic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genmark Diagnostic. Real-time updates on events, politics, business and more.
October 9, 2023
Revenue from the antibiotic susceptibility testing market reached US$ 2.82 billion in 2021. By 2028, the market will have grown at a CAGR of 5.2% and be valued at US$ 4.05 billion.The top five market influencers driving demand and revenue growth for the global Antibiotic Susceptibility Testing Market are tracked in...
February 21, 2023
The Antibiotic Susceptibility Testing Market generated US$2.82 billion in sales in 2021. By 2028, the global market is projected to have grown at a CAGR of 5.2% and be worth US$ 4.05 billion.A recently published research intelligence on the global antibiotic susceptibility testing market share by Future Market Insig...
October 17, 2022
North American region accounts for 28.6% share of the global Antibiotic Susceptibility Testing Market. Get comprehensive data insights on other growth fact
October 17, 2022
North American region accounts for 28.6% share of the global Antibiotic Susceptibility Testing Market. Get comprehensive data insights on other growth fact
October 17, 2022
North American region accounts for 28.6% share of the global Antibiotic Susceptibility Testing Market. Get comprehensive data insights on other growth fact
September 8, 2022
A recently published research intelligence on the global antibiotic susceptibility testing market by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.Infectious diseases, prevailing at a high paceIncreasing rate and tenure of hospitalizationGrow...
March 16, 2022
Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST). Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced s...
April 22, 2021
Share: Basel, 22 April 2021 - Roche ((SIX: RO, ROG, OTCQX:RHHBY) and GenMark Diagnostics, Inc. today announced that Roches wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) at a price of USD 24.05 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 21 Ap...